E-LIB Suche - Ergebnisse für: Allan, John N.

1

First‐line ibrutinib treatment in patients with chronic lym..:

Ghia, Paolo ; Owen, Carolyn ; Allan, John N....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

An indirect comparison of acalabrutinib with and without ob..:

Kittai, Adam S. ; Allan, John N. ; James, Dan...
Blood Advances. 8 (2024) 11 - p. 2861-2869 , 2024

Link: https://doi.org/10.1182/..

3

Treatment Discontinuation Patterns for Patients With Chroni..:

Shadman, Mazyar ; Manzoor, Beenish S. ; Sail, Kavita...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 7 - p. 515-526 , 2023

Link: https://doi.org/10.1016/..

4

Primary Effusion Lymphoma in an HIV-Negative Patient with C..:

SahBandar, Ivo N. ; Sy, Chandler B. ; van den Akker, Tayler...
Pathobiology. 90 (2023) 5 - p. 356-364 , 2023

Link: https://doi.org/10.1159/..

5

Hyperphosphorylation of BCL-2 family proteins underlies fun..:

Chong, Stephen Jun Fei ; Zhu, Fen ; Dashevsky, Olga...
Journal of Clinical Investigation. 133 (2023) 22 - p. , 2023

Link: https://doi.org/10.1172/..

6

The immunomodulatory molecule TIGIT is expressed by chronic..:

Arruga, Francesca ; Rubin, Marta ; Papazoglou, Despoina...
Haematologica. 108 (2023) 8 - p. 2101-2115 , 2023

Link: https://doi.org/10.3324/..

7

Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lympho..:

Jain, Nitin ; Croner, Lisa J. ; Allan, John N....
Clinical Cancer Research. 30 (2023) 3 - p. 498-505 , 2023

Link: https://doi.org/10.1158/..

8

Angioimmunoblastic T‐cell lymphoma presenting with severe p..:

Mejia Saldarriaga, Mateo ; Alhomoud, Mohammad ; Roboz, Gail...
American Journal of Hematology. 98 (2023) 7 - p. 1119-1126 , 2023

Link: https://doi.org/10.1002/..

9

XPO1 Enables Adaptive Regulation of mRNA Export Required fo..:

Marullo, Rossella ; Rutherford, Sarah C. ; Revuelta, Maria V....
Cancer Research. 84 (2023) 1 - p. 101-117 , 2023

Link: https://doi.org/10.1158/..

10

Outcomes in Patients with High-Risk Features after Fixed-Du..:

Allan, John N. ; Flinn, Ian W. ; Siddiqi, Tanya...
Clinical Cancer Research. 29 (2023) 14 - p. 2593-2601 , 2023

Link: https://doi.org/10.1158/..

11

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, Meghan C. ; Harrup, Rosemary A. ; Coombs, Catherine C....
Blood Advances. 6 (2022) 15 - p. 4553-4557 , 2022

Link: https://doi.org/10.1182/..

12

Fixed-duration ibrutinib plus venetoclax for first-line tre..:

Tam, Constantine S. ; Allan, John N. ; Siddiqi, Tanya...
Blood. 139 (2022) 22 - p. 3278-3289 , 2022

Link: https://doi.org/10.1182/..

13

Effective Tumor Debulking with Ibrutinib Before Initiation ..:

Barr, Paul M. ; Tedeschi, Alessandra ; Wierda, William G....
Clinical Cancer Research. 28 (2022) 20 - p. 4385-4391 , 2022

Link: https://doi.org/10.1158/..

14

Phase II study of acalabrutinib in ibrutinib-intolerant pat..:

Rogers, Kerry A. ; Thompson, Philip A. ; Allan, John N....
Haematologica. 106 (2021) 9 - p. 2364-2373 , 2021

Link: https://doi.org/10.3324/..

15

Phase Ib dose-escalation study of the selective, non-covale..:

Allan, John N. ; Pinilla-Ibarz, Javier ; Gladstone, Douglas E....
Haematologica. 107 (2021) 4 - p. 984-987 , 2021

Link: https://doi.org/10.3324/..